Pharma Bury & Co SRL
1.1 FTEPharma Bury & Co reported total assets of €1.63m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026), with 1.1 full-time equivalent.
The score of Pharma Bury & Co shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +172 % Total assets +96 % Headcount (avg FTE) +83 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Bury & Co's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 24 Jul 2025
- Year ended 31 Dec 2023filed on 05 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jul 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Pharma Bury & Co's financial analysis
- Solvency3.9%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Bury & Co
Pharma Bury & Co's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0723.851.414
- VAT number
- BE0723851414
- Peppol
- Registered · 0208:0723851414 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Apr 2019
- Registered office
- 6150 Anderlues
- Size
- Micro · 1.1 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Bury & Co (SRL) has been based in Anderlues since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 10,452 € and equity of 64,178 €; its revenue is not published. With 1.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 3.9%, below the median of its sector (40.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma Bury & Co
Companies in the same business, of comparable size and area, outside its group.
- ANAP Retail sale of pharmaceutical products Aalst · balance sheet €1.37m
- Apotheek Goddeeris Retail sale of pharmaceutical products Genk · balance sheet €1.41m
- Idespharma Retail sale of pharmaceutical products Koksijde · balance sheet €1.34m
- Vabo Pharma Retail sale of pharmaceutical products Menen · balance sheet 960,813 €
- Lesage - Vandevelde Retail sale of pharmaceutical products Oudenburg · balance sheet €1.21m
- MAHO Retail sale of pharmaceutical products Tienen · balance sheet €1.00m
- JLV Consult Retail sale of pharmaceutical products Thuin · balance sheet €2.53m
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
Frequently asked questions about Pharma Bury & Co
What is the revenue of Pharma Bury & Co?
Pharma Bury & Co files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Bury & Co?
In Belgium, the VAT number is the company number prefixed with BE: BE0723851414 for Pharma Bury & Co, if the company is VAT-registered. Its company number (CBE) is 0723.851.414.
Where is the registered office of Pharma Bury & Co?
According to the CBE register, the registered office of Pharma Bury & Co is in 6150 Anderlues.
What is the equity of Pharma Bury & Co?
At the close of the 2025 financial year, the equity of Pharma Bury & Co amounts to 64,178 €, a solvency of 3.9% of total assets.
How many people work at Pharma Bury & Co?
1.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma Bury & Co?
The register lists 2 active mandates at Pharma Bury & Co. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Bury & Co
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →